Invasive_urothelial_carcinoma

Invasive urothelial carcinoma

Invasive urothelial carcinoma

Medical condition


Invasive urothelial carcinoma is a type of transitional cell carcinoma. It is a type of cancer that develops in the urinary system: the kidney, urinary bladder, and accessory organs. Transitional cell carcinoma is the most common type of bladder cancer and cancer of the ureter, urethra, renal pelvis, the ureters, the bladder, and parts of the urethra and urachus.[1][2] It originates from tissue lining the inner surface of these hollow organs - transitional epithelium.[3][4] The invading tumors can extend from the kidney collecting system to the bladder.[5]

Quick Facts Specialty ...

Carcinoma (from the Greek karkinos, or "crab", and -oma, "growth") is a type of cancer.[6] A carcinoma is a cancer that begins in a tissue that lines the inner or outer surfaces of the body, and that generally arises from cells originating in the endodermal or ectodermal germ layer during embryogenesis.

Symptoms

Symptoms vary between individuals and can be dependent upon the stage of growth of the carcinoma. Presence of the carcinoma can lead to be asymptomatic blood in the urine (hematuria), Hematuria can be visible or detected microscopically. Visible hematuria is when urine appears red or brown and can be seen with the naked eye. Other symptoms are not specific. Other inflammatory conditions that affect the bladder and kidney can create similar symptoms. Early detection facilitates curing the disease. Other symptoms can involve:

  • pain or burning on urination
  • the sensation of not being able to completely empty the bladder
  • the sensation of needing to urinate more often or more frequently than normal

These symptoms are general and also indicate less serious problems.[7]

Prognosis and treatment

Prognosis is highly variable and dependent upon a multitude of factors. Reoccurrence does occur.[8] Treatment is determined on a case-by-case basis.[9][10]

See also

Transitional epithelium


References

  1. Andersson, 2011: p. 134
  2. Amornpan, Ajjimaporn; Botsford, Tom; Garrett, Scott H; Sens, Mary Ann; Zhou, Xu Dong; Dunlevy, Jane R; Sens, Donald A; Somji, Seema (2012-07-04). "ZIP8 expression in human proximal tubule cells, human urothelial cells transformed by Cd+2 and As+3 and in specimens of normal human urothelium and urothelial cancer". Cancer Cell Int. 12 (16): 16. doi:10.1186/1475-2867-12-16. PMC 3390278. PMID 22550998.
  3. "Definition of Carcinoma". Archived from the original on 2012-10-10. Retrieved 2017-06-12.
  4. Selvaraj V, Govindarajan P, Deepak M, Sivaraj M. "The creeping tumor:" An unusual presentation of upper urinary tract malignancy. Indian J Urol 2014;30:454-5.
  5. Lemoine, Nigel Kirkham, Nicholas R. (2001). Progress in pathology. London: Greenwich Medical Media. p. 52. ISBN 9781841100500.{{cite book}}: CS1 maint: multiple names: authors list (link)
  6. "Bladder Cancer: SYMPTOMS OF BLADDER CANCER". Johns Hopkins University. Retrieved 2015-03-04.
  7. May M, Brookman-Amissah S, Roigas J, et al. (March 2009). "Prognostic Accuracy of Individual Uropathologists in Noninvasive Urinary Bladder Carcinoma: A Multicentre Study Comparing the 1973 and 2004 World Health Organisation Classifications". Eur. Urol. 57 (5): 850–8. doi:10.1016/j.eururo.2009.03.052. PMID 19346063.
  8. Babjuk, M.; Oosterlinck, W.; Sylveste, R.; Kaasinen, E.; Böhle, A.; Palou-Redorta, J.; Rouprêt, M. (July–August 2012). "EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update". Actas Urológicas Españolas (English Edition). 36 (7): 389–402. doi:10.1016/j.acuroe.2011.12.007. PMID 22386115.

Bibliography


Share this article:

This article uses material from the Wikipedia article Invasive_urothelial_carcinoma, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.